» Articles » PMID: 2013838

The Pharmacokinetics of Aspirin in Rats and the Effect of Buffer

Overview
Specialty Pharmacology
Date 1991 Apr 1
PMID 2013838
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Aspirin (acetylsalicyclic acid) was administered to rats intravenously, orally, and intraintestinally at different doses or in different dosage forms. The distribution and elimination kinetics of aspirin in rats following intravenous administration were best described by a two-compartmental open system and were dose independent up to 15 mg/kg. The terminal elimination half-life following intravenous dosing (10 mg/kg) was 3.36 +/- 0.85 min (n = 15) with the clearance being 8.40 +/- 1.24 L/(kg.hr). Intravenous distribution and elimination kinetics of aspirin in rats were not influenced by an orally administered buffered solution with a buffer capacity of 0.933 mEq ANC (acid neutralizing capacity) per kg of body weight. However, this orally buffered solution did change the gastrointestinal absorption kinetics of aspirin in rats. The absolute bioavailable dose of aspirin was 56.6 +/- 10.4% (n = 6) following its administration in an unbuffered solution while it was only 31.8 +/- 8.0% (n = 6) following administration in the buffered solution. The corresponding values of the absolute bioavailable doses were 43.4 +/- 3.7% and 25.5 +/- 1.8% following intraintestinal administration. The lower systemic availability of aspirin in the presence of buffer is attributed to a greater fraction of the administered dose becoming available for absorption from the intestine where the extraction efficiency is higher than that in the stomach.

Citing Articles

Synthesis, Characterization, and Application of 2-((3-(Chloromethyl)-benzoyl)oxy)benzoic Acid: A Review.

Tjahjono Y, Caroline , Foe K, Karnati S, Ergun S, Esar S ACS Omega. 2023; 8(1):42-47.

PMID: 36643478 PMC: 9835159. DOI: 10.1021/acsomega.2c05566.


Development and Pharmacokinetics of a Novel Acetylsalicylic Acid Dry Powder for Pulmonary Administration.

Paclawski A, Politis S, Balafas E, Mina E, Papakyriakopoulou P, Christodoulou E Pharmaceutics. 2022; 14(12).

PMID: 36559312 PMC: 9786194. DOI: 10.3390/pharmaceutics14122819.


Acetylsalicylic Acid Suppresses Alcoholism-Induced Cognitive Impairment Associated with Atorvastatin Intake by Targeting Cerebral miRNA155 and NLRP3: In Vivo, and In Silico Study.

Mohamed D, Alaa El-Din Aly El-Waseef D, Nabih E, El-Kharashi O, Abd El-Kareem H, Abo Nahas H Pharmaceutics. 2022; 14(3).

PMID: 35335908 PMC: 8948796. DOI: 10.3390/pharmaceutics14030529.


Effects of dexamethasone and acetylsalicylic acid on inflammation caused by Complete Freund's adjuvant in the naked mole rat ().

Thuo J, Towett P, Kanui T, Abelson K Heliyon. 2022; 8(2):e08920.

PMID: 35198780 PMC: 8850730. DOI: 10.1016/j.heliyon.2022.e08920.


Utility of Platelet Endothelial Cell Adhesion Molecule 1 in the Platelet Activity Assessment in Mouse and Human Blood.

Marcinczyk N, Misztal T, Gromotowicz-Poplawska A, Zebrowska A, Rusak T, Radziwon P Int J Mol Sci. 2021; 22(17).

PMID: 34502520 PMC: 8431756. DOI: 10.3390/ijms22179611.


References
1.
Rowland M, RIEGELMAN S, Harris P, Sholkoff S . Absorption kinetics of aspirin in man following oral administration of an aqueous solution. J Pharm Sci. 1972; 61(3):379-85. DOI: 10.1002/jps.2600610312. View

2.
SCHANKER L, TOCCO D, Brodie B, Hogben C . Absorption of drugs from the rat small intestine. J Pharmacol Exp Ther. 1958; 123(1):81-8. View

3.
Wientjes M, Levy G . Nonlinear pharmacokinetics of aspirin in rats. J Pharmacol Exp Ther. 1988; 245(3):809-15. View

4.
Rothschild B . Hematologic perturbations associated with salicylate. Clin Pharmacol Ther. 1979; 26(2):145-52. DOI: 10.1002/cpt1979262145. View

5.
Harris P, RIEGELMAN S . Influence of the route of administration on the area under the plasma concentration-time curve. J Pharm Sci. 1969; 58(1):71-5. DOI: 10.1002/jps.2600580114. View